SLC22A10: A Potential Drug Target and Biomarker (G387775)

Target Name: SLC22A10

NCBI ID: G387775

SLC22A10

SLC22A10: A Potential Drug Target and Biomarker

SLC22A10 is a gene that encodes a protein known as solute carrier family 22 member 10. The protein is a member of the SLC22 family, which is known for its role in transporting various substances across cell membranes. SLC22A10 is unique because it has a variable region, which allows it to transport a wide range of different molecules.

One of the key functions of SLC22A10 is its role in the transport of nucleotides, such as adenosine and guanosine. These molecules are important for various cellular processes, including signaling and replication. SLC22A10 is also involved in the transport of other small molecules, such as amino acids and nucleotides.

SLC22A10 is a protein that has been identified as a potential drug target. Its role in the transport of nucleotides and other small molecules makes it an attractive target for drugs that are designed to modulate these processes. For example, SLC22A10 has been shown to play a role in the regulation of cell signaling pathways, which makes it a potential target for drugs that are used to treat a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its potential as a drug target, SLC22A10 is also a potential biomarker. Its unique structure and function make it an attractive candidate for use as a diagnostic or predictive marker for a wide range of diseases. For example, SLC22A10 has been shown to be expressed at higher levels in tissues of individuals with certain types of cancer, which makes it a potential biomarker for cancer.

SLC22A10 is also a potential target for drug development because of its unique structure and function. Its variable region allows it to transport a wide range of different molecules, which makes it an attractive target for drugs that are designed to modulate these processes. For example, SLC22A10 has been shown to play a role in the regulation of cell signaling pathways, which makes it a potential target for drugs that are used to treat a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

In conclusion, SLC22A10 is a gene that encodes a protein with unique structure and function. Its role in the transport of nucleotides and other small molecules makes it an attractive target for drugs that are designed to modulate these processes. Its variable region also makes it a potential target for drug development, as it allows it to transport a wide range of different molecules. Additionally, SLC22A10 is a potential biomarker that has been shown to be expressed at higher levels in tissues of individuals with certain types of cancer. Further research is needed to fully understand the role of SLC22A10 in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: Solute Carrier Family 22 Member 10

The "SLC22A10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC22A10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets